$536.55
2.07% yesterday
Nasdaq, Nov 25, 10:01 pm CET
ISIN
US46120E6023
Symbol
ISRG
Sector

Intuitive Surgical Stock price

$536.55
+25.28 4.94% 1M
+131.70 32.53% 6M
+199.19 59.04% YTD
+221.57 70.34% 1Y
+197.13 58.08% 3Y
+342.72 176.81% 5Y
+479.16 834.95% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-11.32 2.07%
ISIN
US46120E6023
Symbol
ISRG
Sector

Key metrics

Market capitalization $191.11b
Enterprise Value $186.97b
P/E (TTM) P/E ratio 86.24
EV/FCF (TTM) EV/FCF 319.06
EV/Sales (TTM) EV/Sales 23.77
P/S ratio (TTM) P/S ratio 24.29
P/B ratio (TTM) P/B ratio 12.26
Revenue growth (TTM) Revenue growth 14.83%
Revenue (TTM) Revenue $7.87b
EBIT (operating result TTM) EBIT $2.06b
Free Cash Flow (TTM) Free Cash Flow $586.00m
Cash position $4.23b
EPS (TTM) EPS $6.22
P/E forward 89.30
P/S forward 23.46
EV/Sales forward 22.95
Short interest 1.09%
Show more

Create a Free Account to create an Intuitive Surgical alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Intuitive Surgical Stock Analysis

Analyst Opinions

30 Analysts have issued a Intuitive Surgical forecast:

21x Buy
70%
9x Hold
30%

Analyst Opinions

30 Analysts have issued a Intuitive Surgical forecast:

Buy
70%
Hold
30%

Financial data from Intuitive Surgical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
7,867 7,867
15% 15%
100%
- Direct Costs 2,598 2,598
13% 13%
33%
5,269 5,269
16% 16%
67%
- Selling and Administrative Expenses 1,643 1,643
11% 11%
21%
- Research and Development Expense 1,111 1,111
13% 13%
14%
2,516 2,516
20% 20%
32%
- Depreciation and Amortization 451 451
11% 11%
6%
EBIT (Operating Income) EBIT 2,064 2,064
22% 22%
26%
Net Profit 2,243 2,243
48% 48%
29%

In millions USD.

Don't miss a Thing! We will send you all news about Intuitive Surgical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Intuitive Surgical Stock News

Positive
Seeking Alpha
7 days ago
Intuitive Surgical has become a leader for numerous procedures, and we expect it to continue its growth. The company is seeing double-digit growth both in systems and consumables driving revenue. We expect the company to continue its growth and returns making it a valuable investment.
Positive
The Motley Fool
17 days ago
These stocks may have done well this year, but here's the case for owning them for another two decades or more.
Positive
MarketBeat
27 days ago
Investors looking for health-related buy-and-hold stocks must look no further than this list. The stocks on this list are market leaders in healthcare, producing sustainable growth with healthy balance sheets, impressive value, and broad market support.
More Intuitive Surgical News

Company Profile

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Head office United States
CEO Gary Guthart
Employees 13,676
Founded 1995
Website www.intuitive.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today